Quantcast

Latest HIV/AIDS Stories

2014-04-02 20:22:23

LOS ANGELES, April 2, 2014 /PRNewswire-USNewswire/ -- On March 19 the Centers for Disease Control and Prevention (CDC) awarded $115 million over five years to 21 organizations to provide technical assistance to health departments and organizations implementing CDC's new prevention strategies and improving health outcomes for people living with HIV/AIDS. Not one of these organizations is a Black organization. The effect of this decision is that Black organizations have been locked out...

2014-04-02 12:07:35

Researchers offer immediate steps to address rise in deaths There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment. These are the findings of a comparative review of HIV/AIDS and addiction by researchers Josiah D. Rich, M.D., M.P.H., director of the Center for Prisoner Health and Human Rights, based at The Miriam...

2014-04-01 16:25:28

Elizabeth Glaser Pediatric AIDS Foundation Applauds Agreement between the Medicines Patent Pool and ViiV Healthcare WASHINGTON, April 1, 2014 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare to increase access to dolutegravir (DTG), a promising new antiretroviral (ARV) medication. This agreement will allow generic manufacturers to scale up production of...

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2014-04-01 16:25:15

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/ -- ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug...

2014-04-01 14:04:36

Pressure from counselors and perceived ineffectiveness & irrelevance of intervention keep young adults from returning to follow-up sessions Keeping young people in human immunodeficiency virus (HIV) prevention programs is a major goal in reducing the incidence of HIV, and multi-session interventions are often more effective than single-sessions. But according to a new study from the Annenberg School for Communication, the way these programs are designed and implemented may turn off the...

2014-04-01 12:56:08

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine. The finding is important, investigators say, because advances in treatment have led to long-term survival of people living with HIV/AIDS and the...

2014-04-01 08:28:25

RARITAN, N.J., April 1, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen), today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a once-daily fixed-dose antiretroviral combination tablet containing darunavir, a protease inhibitor developed by Janssen R&D Ireland and marketed as PREZISTA(®) in the U.S., with cobicistat, an investigational pharmacokinetic enhancer or boosting agent, developed...

2014-04-01 08:26:47

National "GYT: Get Yourself Tested" Campaign Successfully Reaching Youth to Increase STD Awareness and Testing, According to New Study NEW YORK, April 1, 2014 /PRNewswire-USNewswire/ -- The sixth annual national GYT: Get Yourself Tested campaign will kick off on Tuesday, April 1, in honor of National STD Awareness Month, with on-air, online, and on-the-ground activities across the country. GYT is designed to promote sexual health and address the disproportionately high rates of sexually...

2014-03-31 20:21:42

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine) has announced the addition of the "HIV Vaccine Market Opportunity & Clinical Pipeline Analysis" [http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Ever since HIV was identified as the cause for AIDS 30 years ago, the HIV virus has become...


Latest HIV/AIDS Reference Libraries

Sooty Mangabey, Cercocebus atys
2014-04-17 14:17:40

The Sooty Mangabey (Cercocebus atys) is an Old World monkey located in forests from Senegal east to Ghana. While overall rated as Vulnerable, the eastern race, lunulatus, known also as the White-Crowned, White-Naped, or White-Collared Mangabey, is considered to be Endangered by the IUCN Red List. They Sooty Mangabey reside in both old growth and secondary forests in addition to flooded, dry, swamp, mangrove, and gallery forests. The primate is arboreal and diurnal. They are omnivores whose...

Journal of Acquired Immune Deficiency Syndromes
2012-05-16 12:01:26

The Journal of Acquired Immune Deficiency Syndromes is a peer-reviewed medical journal established in 1988 and is currently published by Lippincott Williams & Wilkins. The journal was renamed ‘Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology’ in 1995, and then returned to its original title in 1999. The journal was the official publication of the International Retrovirology Association until 2000. This journal covers aspects of research in HIV/AIDS, including...

AIDS
2012-05-07 07:38:24

AIDS is a peer-reviewed scientific journal published 18 times yearly by Lippincott Williams & Wilkins, London, UK. It was established in 1987 and is the official journal of the International AIDS Society. It covers all aspects of HIV and AIDS research, including basic science, clinical trials, epidemiology, and social science. As of May 2012, the editor-in-chief is Jay A. Levy. AIDS has been cited as the most read journal in its area of science and has the highest impact of all...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

0_336928514f8c16d00d00e956be85245d
2011-02-17 15:06:48

Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...

More Articles (6 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.